The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 3030-3042

  Rainczuk, A ^a,b,d   Smooker, P M ^c   Kedzierski, L ^b,e   Black, C G ^b   Coppel, R L ^b   Spithill, T W ^d  

^a Department of Civil and Environmental Engineering   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d MCGILL UNIVERSITY   (Canada)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

DNA vaccine; Gene gun; Malaria; MCP 3; MSP4 5; Prime boost

Indexed keywords

ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA VACCINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1; MEROZOITE SURFACE PROTEIN 4; MEROZOITE SURFACE PROTEIN 5; MONOCYTE CHEMOTACTIC PROTEIN 3; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DNA VECTOR; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SYNTHESIS; FEMALE; GENE CONSTRUCT; GENE GUN; IMMUNIZATION; LETHALITY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROVOCATION TEST; SEQUENCE HOMOLOGY; SURVIVAL; VACCINATION;

EID: 0037498615     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00116-6     Document Type: Article

References (35)

1. Kumar S., Epstein J.E., Richie T.L.et al. A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol. 18(3):2002;129-135.
2. Gilbert S.C., Schneider J., Hannan C.M.et al. Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine. 20:2002;1039-1045.
3. Doolan D.L., Hoffman S.L. DNA-based vaccines against malaria: status and promise of the multi-stage malaria DNA vaccine operation. Int. J. Parasitol. 31:2001;753-762.
4. + T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization. J. Immunol. 165:2000;389-396.
5. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69(5):2001;3286-3294.
6. Hirunpetcharat C., Vukovic P., QinLiu X., Kaslow D.C., Miller L.H., Good M.F. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1. J. Immunol. 162:1999;7309-7314.
7. Daly T.M., Long C.A. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:1995;236-243.
8. Haddad D., Liljeqvist S., Stahl S.et al. Charaterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol. Scand. J. Immunol. 49:1999;506-514.
9. Jones T.R., Narum D.L., Gozalo A.S.et al. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J. Infect. Dis. 183:2001;303-312.
10. Kumar S., Villinger F., Oakley M.et al. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-g and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol. Lett. 81:2002;13-24.
11. Hoffman S.L., Doolan D.L. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization? Dev. Biol. Basel. 104:2000;121-132.
12. Mumper R.J., Ledebur H.C. Jr. Dendritic cell delivery of plasmid DNA. Mol. Biotechnol. 19:2001;79-95.
13. Boyle J.S., Brady J.L., Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature. 392:1998;408-411.
14. Lew A.M., Brady J.L., Boyle J.S. Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions. Vaccine. 18:2000;1681-1685.
15. Drew D.R., Boyle J.S., Lew A.M., Lightowlers M.W., Chaplin P.J., Strugnell R.A. The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep. Vaccine. 19:2001;4417-4428.
16. Biragyn A., Tani K., Grimm M.C., Weeks S., Kwak L.W. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nature Biotechnol. 17:1999;253-258.
17. Black C.G., Wang L., Hibbs A.R., Werner E., Coppel R.L. Identification fo the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum. Infect. Immun. 67:1999;2075-2081.
18. Kedzierski L., Black C.G., Coppel R.L. Characterisation of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii. Mol. Biochem. Parasitol. 105:2000;137-147.
19. Kedzierski L., Black C.G., Coppel R.L. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge. Infect. Immun. 68(10):2000;6034-6037.
20. Hartikka J., Sawdey M., Cornefert-Jensen F.et al. An improved plasmid DNA expression vector for direct injection in skeletal muscle. Human Gene Therap. 7:1996;1205-1217.
21. Devey M.E., Bleasdale K., Lee S., Rath S. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J. Immunol. Meth. 106(1):1988;119-125.
22. Good M.F., Doolan D.L. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11:1999;412-419.
23. Kang Y., Calvo P.A., Daly T.M., Long C.A. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. J. Immunol. 161:1998;4211-4219.
24. Crewther P.E., Matthew M.L.S.M., Flegg R.H., Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64:1996;3310-3317.
25. Anders R.F., Crewther P.E., Edwards S.et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine. 16:1998;240-247.
26. Deliyannis G., Boyle J.S., Brady J.L., Brown L.E., Lew A.M. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Natl. Acad. Sci. U.S.A. 97(12):2000;6676-6680.
27. Menten P., Wuyts A., Van Damme J. Monocyte chemotactic protein-3. Euro. Cytokine Network. 12(4):2001;554-560.
28. Haddad D., Ramprakash J., Sedegah M.et al. Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J. Immunol. 165:2000;3772-3781.
29. Coombes B.K., Mahony J.B. Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines. Immunol. Lett. 78:2001;103-111.
30. Weiss R., Leitner W.W., Scheiblhofer S.et al. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. Infect. Immun. 68(10):2000;5914-5919.
31. Kaur R., Sachdeva G., Vrati S. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J. Infect. Dis. 185(1):2002;1-12.
32. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicted by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70(9):1996;119-6125.
33. Kedzierski L., Black C.G., Stowers A.W., Goschnick M.W., Kaslow D.C., Coppel R.L. Comparison of the protective efficacy of yeast-derived and Eschericia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii. Vaccine. 19:2001;4661-4668.
34. Cavinato R.A., Bastos K.R.B., Sardinha L.R., Elias R.M., Alvarez J.M., D'Imperio Lima M.R. Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab′)2 fragments. Parasite Immunol. 23:2001;587-597.
35. Boyle J.S., Silva A., Brady J.L., Lew A.M. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14626-14631.